Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
2.180
+0.170 (8.46%)
At close: Nov 21, 2024, 4:00 PM
2.140
-0.040 (-1.83%)
After-hours: Nov 21, 2024, 5:01 PM EST

Taysha Gene Therapies Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
157.69143.9487.88149.1251.25-
Cash & Short-Term Investments
157.69143.9487.88149.1251.25-
Cash Growth
-4.01%63.79%-41.06%-40.66%--
Prepaid Expenses
1.871.092.513.873.83-
Restricted Cash
0.450.45----
Other Current Assets
1.554.396.036.632.790.02
Total Current Assets
161.56149.8796.42159.6257.880.02
Property, Plant & Equipment
16.2920.4125.9150.610.29-
Other Long-Term Assets
2.372.463.953.740.72-
Total Assets
180.22172.73126.28213.96258.880.02
Accounts Payable
4.936.3710.9521.761.99-
Accrued Expenses
9.49.4614.0425.854.870.13
Current Portion of Leases
1.821.651.52---
Current Unearned Revenue
11.818.1133.56---
Other Current Liabilities
1.41.182.734.140.260.02
Total Current Liabilities
29.3436.7662.7951.757.130.15
Long-Term Debt
42.9740.5137.9737.19--
Long-Term Leases
18.2319.7320.4425.9--
Other Long-Term Liabilities
0.880.84.133.740.45-
Total Liabilities
91.4297.79125.33118.577.580.15
Common Stock
000---
Additional Paid-In Capital
674.64587.94402.39331.03312.430.98
Retained Earnings
-583.52-513.01-401.44-235.65-61.13-1.12
Shareholders' Equity
88.874.940.9595.38251.3-0.14
Total Liabilities & Equity
180.22172.73126.28213.96258.880.02
Total Debt
63.0261.8959.9363.09--
Net Cash (Debt)
94.6782.0627.9586.01251.25-
Net Cash Growth
-9.20%193.56%-67.50%-65.77%--
Net Cash Per Share
0.400.710.642.2814.22-
Filing Date Shares Outstanding
204.94187.0263.4738.4737.7610.9
Total Common Shares Outstanding
204.94186.9663.2138.4737.7610.9
Working Capital
132.22113.1133.63107.86250.75-0.14
Book Value Per Share
0.430.400.022.486.65-0.01
Tangible Book Value
88.874.940.9595.38251.3-0.14
Tangible Book Value Per Share
0.430.400.022.486.65-0.01
Machinery
5.184.874.883.040.1-
Construction In Progress
4.246.829.63460.2-
Leasehold Improvements
2.122.122.092.07--
Source: S&P Capital IQ. Standard template. Financial Sources.